Lineage Cell Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -3.52M-9.85M-18.44M-25.31M-56.19M-51.16M-62.65M18.62M-23.29M-47.48M-11.83M-20.68M-43.27M-26.35M-21.48M-18.58M
Depreciation and Depletion 0.03M0.14M0.37M0.39M0.66M1.05M1.08M
Share-based Compensation -0.48M1.09M1.80M1.84M3.22M4.46M11.05M7.95M3.93M298.00M3.58M2.23M3.52M4.29M4.64M5.08M
Deferred Taxes -3.28M-7.38M-4.52M-1.24M-1.80M
Gains from Sales and Divestitures 12.24M0.22M0.08M0.56M0.00M0.10M0.04M0.00M0.00M0.07M0.06M0.03M0.08M0.07M
Gains from Investment Securities 0.09M4.31M8.80M7.82M0.17M0.12M0.50M0.63M1.75M0.10M-0.27M0.02M-0.02M0.37M0.05M-2.13M
Asset Writedowns and Impairment 0.00M0.00M0.10M0.02M-0.01M-0.02M0.95M
Non-cash Items 3.19M5.61M8.39M0.00M0.00M3.70M6.30M0.01M0.01M6.39M8.86M1.05M8.20M
Cash from Operations -4.26M-7.73M-13.59M-19.68M-29.51M-38.85M-44.54M-42.33M-30.52M-30.88M-31.95M-19.75M-23.56M1.06M-28.57M-23.09M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.79M1.99M2.45M3.30M7.36M5.26M3.58M2.35M2.19M2.00M1.22M0.21M0.14M0.13M0.02M
Amortization of Deferred Charges -0.29M-0.23M-0.21M-0.92M-0.00M0.10M0.02M
Depreciation & Amortization (CF) 0.03M0.14M0.37M0.20M0.68M1.05M1.08M1.18M0.95M1.08M1.00M0.82M0.66M0.58M0.56M0.59M
Change in Working Capital
Change in Receivables 0.00M0.08M0.12M-0.21M0.18M0.07M0.08M-0.19M0.17M-0.05M-0.47M-0.29M0.86M-50.31M0.45M-0.11M
Change in Inventory 0.04M0.01M-0.03M0.00M0.12M0.09M0.07M
Change in Accured Expenses -0.42M0.25M0.60M0.91M2.14M-0.47M1.67M0.01M1.30M1.10M-2.88M0.31M21.64M-18.70M-2.29M-1.68M
Other Working Capital Changes 0.15M0.39M0.70M0.23M-0.43M-0.16M1.53M1.11M0.24M0.44M0.26M-1.57M0.38M-13.35M-7.64M-7.68M
Investing Activities
Capital Expenditures 0.06M0.22M0.96M0.40M2.28M0.48M4.09M2.25M1.33M0.86M0.44M0.06M0.34M0.41M0.67M0.56M
Sales of Property, Plant and Equipment 0.01M0.00M0.03M0.01M0.20M0.08M0.02M0.01M
Acquisitions 0.14M0.25M0.29M3.12M
Divestments 0.04M4.67M3.21M
Change in Acquisitions & Divestments 7.67M63.33M7.00M
Cash from Investing Activities -0.05M3.20M-1.20M-0.10M-3.67M-1.01M-7.44M-10.89M-10.22M11.82M16.96M13.04M9.74M-46.16M46.45M-2.31M
Financing Activities
Other financing activities 4.00M2.30M3.21M0.25M5.25M0.47M13.64M0.17M5.00M3.50M2.23M3.52M0.11M0.04M0.02M
Cash from Financing Activities 16.48M25.77M3.86M1.91M34.26M63.62M64.78M32.78M55.39M5.77M0.62M29.86M36.93M1.63M6.42M35.86M
Additional items
Exchange Rate Effect -0.10M-0.18M0.01M0.06M0.23M-0.05M0.29M0.10M0.01M0.07M-0.06M-0.02M-0.87M-0.25M-0.10M
Change in Cash 12.18M21.14M-11.11M-17.86M1.15M23.99M12.74M-20.14M14.75M-13.29M-14.30M23.09M23.09M-44.34M24.06M10.36M
Free Cash Flow -4.32M-7.95M-14.55M-20.08M-31.79M-39.34M-48.64M-44.57M-31.84M-31.74M-32.39M-19.82M-23.90M0.65M-29.24M-23.66M
Net Cash Flow 12.18M21.23M-10.93M-17.87M1.09M23.76M12.79M-20.43M14.65M-13.29M-14.37M23.15M23.11M-43.47M24.31M10.46M